Diabetes and cardiovascular risk evaluation and management in primary care:: progress and unresolved issues -: Rationale for a nationwide primary care project in Germany

被引：8

作者：

Böhler, S

Glaesmer, H

Pittrow, D

Lehnert, H

Stalla, GK

Zeiher, AM

März, W

Silber, S

Wehling, M

Ruf, G

Reinecke, A

机构：

[1] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-8027 Dresden, Germany

[2] Pfizer GmbH, Int Med Res, Freiburg, Germany

[3] Tech Univ Dresden, Inst Clin Pharmacol, Res Fed Publ Hlth Sachsen, D-8027 Dresden, Germany

[4] Otto Von Guericke Univ, Dept Endocrinol & Metab Disorders, Magdeburg, Germany

[5] Max Planck Inst Psychiat, Dept Endocrinol, D-80804 Munich, Germany

[6] Goethe Univ Frankfurt, Dept Cardiol Nephrol, D-6000 Frankfurt, Germany

[7] Univ Med Graz, Clin Inst Med & Chem, Diagnost Lab, Graz, Austria

[8] Heidelberg Univ, Inst Clin Pharmacol Mannheim, D-68167 Mannheim, Germany

[9] Pfizer GmbH, Clin Res, Karlsruhe, Germany

[10] Max Planck Inst Psychiat, Dept Clin Psychol & Epidemiol, D-80804 Munich, Germany

来源：

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2004年 / 112卷 / 04期

关键词：

coronary heart disease; type 2 diabetes mellitus; primary care; risk markers; epidemiology;

D O I：

10.1055/s-2004-817927

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review highlights established and more recently recognized risk factors for coronary heart disease (CHD) relevant for patients seen in primary care, emphasizing the key role of diabetes mellitus type 2. Recent trends in risk factor research as well as current methods of risk stratification, and new systemic markers are discussed. Beyond the need for more forceful public health strategies to improve early recognition and intervention, the necessity of an integrated comprehensive investigation of the overall characteristics of cardiovascular disease, especially in primary care patients as a prerequisite for future concerted actions is pointed out. Based on this, a large-scale epidemiological investigation focusing on CHD and diabetes in the primary care sector is suggested.

引用

页码：157 / 170

页数：14

共 138 条

[1] VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL [J].

ABRAIRA, C ;

COLWELL, JA ;

NUTTALL, FQ ;

SAWIN, CT ;

NAGEL, NJ ;

COMSTOCK, JP ;

EMANUELE, NV ;

LEVIN, SR ;

HENDERSON, W ;

LEE, HS .

DIABETES CARE, 1995, 18 (08) :1113-1123

[2] Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial - Veterans Affairs Cooperative Study on gylcemic control and complications in type II diabetes [J].

Abraira, C ;

Colwell, J ;

Nuttall, F ;

Sawin, CT ;

Henderson, W ;

Comstock, JP ;

Emanuele, NV ;

Levin, SR ;

Pacold, I ;

Lee, HS ;

Silbert, CK ;

Cxypoliski, R ;

Vasquez, M ;

Kernan, D ;

Niewoehner, C ;

Backes, M ;

Bradley, M ;

Crow, R ;

Rubino, F ;

Bushnell, D ;

Pfeifer, M ;

Service, FJ ;

Howard, B ;

Chew, E ;

Hoogwerf, B ;

Seigel, D ;

Clark, CM ;

Olefsky, JM ;

Porte, D ;

Sussman, KE ;

Johnson, N ;

Christine, B ;

Tir, K ;

Sather, M ;

Day, P ;

Morgan, N ;

Deykin, D ;

Gold, J ;

Huang, P .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (02) :181-188

[3] Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project:: A multinational registry of patients hospitalized with acute coronary syndromes [J].

Agnelli, G ;

Avezum, A ;

Brieger, D ;

Budaj, A ;

Cannon, CP ;

Goldberg, RJ ;

Goodman, S ;

Gulba, DC ;

Granger, C ;

Kennelly, BM ;

Gurfinkel, E ;

López-Sendón, J ;

Klein, W ;

Montalescot, G ;

Van de Werf, F .

AMERICAN HEART JOURNAL, 2001, 141 (02) :190-199

[4] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[5]

[Anonymous], 1997, WORLD HEALTH FORUM, V18, P248

[6] The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making [J].

Antman, EM ;

Cohen, M ;

Bernink, PJLM ;

McCabe, CH ;

Horacek, T ;

Papuchis, G ;

Mautner, B ;

Corbalan, R ;

Radley, D ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07) :835-842

[7] Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].

Assmann, G ;

Cullen, P ;

Schulte, H .

CIRCULATION, 2002, 105 (03) :310-315

[8] THE PROSPECTIVE CARDIOVASCULAR MUNSTER (PROCAM) STUDY - PREVALENCE OF HYPERLIPIDEMIA IN PERSONS WITH HYPERTENSION AND OR DIABETES-MELLITUS AND THE RELATIONSHIP TO CORONARY HEART-DISEASE [J].

ASSMANN, G ;

SCHULTE, H .

AMERICAN HEART JOURNAL, 1988, 116 (06) :1713-1724

[9] Homocysteine and cardiovascular disease in diabetes mellitus [J].

Audelin, MC ;

Genest, J .

ATHEROSCLEROSIS, 2001, 159 (02) :497-511

[10] The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM) [J].

Azad, N ;

Emanuele, NV ;

Abraira, C ;

Henderson, WG ;

Colwell, J ;

Levin, SR ;

Nuttall, FQ ;

Comstock, JP ;

Sawin, CT ;

Silbert, C ;

Rubino, FA .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1999, 13 (5-6) :307-313

← 1 2 3 4 5 6 7 8 9 10 →